小结
定义
病史和查体
诊断性检查
治疗流程
贡献者
作者 查看所有
Melanoma Institute Australia
The University of Sydney
Sydney
Australia
利益冲突披露
AMM has received honoraria from Novartis and BMS. AMM is on the advisory boards of MSD and Chugai.Melanoma Institute Australia
The University of Sydney
Royal Prince Alfred and Mater Hospitals
Sydney
Australia
利益冲突披露
RPMS is on the advisory board for Amgen and has received honoraria from BMS.Associate Professor of Dermatology
The University of Sydney
Sydney
Australia
利益冲突披露
PF-P declares that he has no competing interests with the topic Melanoma. PF-P has advisory roles with Leo, Novartis, Lilly, Abbvie, Janssen, Celgene (psoriasis, atopic eczema, hidradenitis). He has been paid to do research for Incyte Europe Sarl, and clinical trials for Leo, Janssen, Kyowa Hakko Kirin, Xoma, Akaal, Amgen, Merk. PF-P has also been paid for lectures by Abbvie, Amgen, Lilly, Novartis, Janssen.Dr Alexander M. Menzies, Dr Robyn P.M. Saw, and Dr Pablo Fernandez-Peñas would like to gratefully acknowledge Dr Philip Friedlander, Dr Hobart W. Walling, and Dr Brian L. Swick, previous contributors to this monograph. PF is a consultant for Genentech. HWW and BLS declare that they have no competing interests.
同行评议专家 查看所有
Assistant Professor
Department of Pathology and Laboratory Medicine
University of California
Los Angeles
CA
利益冲突披露
DC declares that he has no competing interests.Dermatologist/Dermatologic Surgeon
President of the South Carolina Skin Cancer Center
Greenville
SC
利益冲突披露
JB declares that he has no competing interests.Associate Director
JCCC Women's Cancers Program Area
Jonsson Comprehensive Cancer Center at UCLA
Los Angeles
CA
利益冲突披露
MB declares that she has no competing interests.Medical Director
CancerPartnersUK
London
UK
利益冲突披露
KS declares that he has no competing interests.
使用此内容应接受我们的免责声明。
